Diversion Control Division, US Department of Justice, Drug Enforcement Administration

Manufacturers Notice of Registration - 2003

[Federal Register: August 5, 2003 (Volume 68, Number 150)] [Notices] [Page 46226] From the Federal Register Online via GPO Access [wais.access.gpo.gov] [DOCID:fr05au03-88]


DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled Substances; Notice of Registration

By Notice dated March 14, 2003, and published in the Federal Register on April 2, 2003, (68 FR 16089), Mallinckrodt, Inc., Mallinckrodt & Second Streets, St. Louis, Missouri 63147, made application by renewal to the Drug Enforcement Administration for registration as a bulk manufacturer of the basic classes of controlled substances listed below:

DrugĀ  Schedule
Tetrahydrocannabinols (7370) I
Codeine-N-oxide (9053) I
Dihydromorphine (9145) I
Dihydromorphine (9145) I
Difenoxin (9168) I
Heroin (9200) I
Morphine-N-oxide (9307) I
Nicomorphine (9312) I
Normorphine (9313) I
Norlevorphanol (9634) I
Amphetamine (1100) II
Methamphetamine (1105) II
Methylphenidate (1724) II
Codeine (9050) II
Diprenorphine (9058) II
Etorphine HCL (9059) II
Dihydrocodeine (9120) II
Hydromorphone (9150) II
Oxycodone (9143) II
Diphenoxylate (9170) II
Benzoylecgonine (9180) II
Hydrocodone (9193) II
Levorphanol (9220) II
Meperidine (9230) II
Methadone (9250) II
Methadone Intermediate (9254) II
Metopon (9260) II
Dextropropoxyphene, bulk (9273) II
Morphine (9300) II
Thebaine (9333) II
Opium extracts (9610) II
Opium fluid extract (9620) II
Opium fluid extract (9620) II
Opium tincture (9630) II
Opium, powdered (9639) II
Opium, granulated (9640) II
Levo-alphacetylmethadol (9648) II
Oxymorphone (9652) II
Alfentanil (9737) II
Sufentanil (9740) II
Fentanyl (9801) II

The above cited Notice of Application contained an error in that the drug code for Oxycodone was listed as 9160 rather than 9143. The firm plans to manufacture the listed controlled substances for internal use and for sale to other companies.

No comments or objections have been received. DEA has considered the factors in Title 21, United States Code, section 823(a) and determined that the registration of Mallinckrodt, Inc. to manufacture the listed controlled substances is consistent with the public interest at this time. DEA has investigated Mallinckrodt, Inc. to ensure that the company's registration is consistent with the public interest. This investigation has included inspection and testing of the company's physical security systems, verification of the company's compliance with state and local laws, and a review of the company's background and history. Therefore, pursuant to 21 U.S.C. 823 and 28 CFR 0.100 and 0.104, the Deputy Assistant Administrator, Office of Diversion Control, hereby orders that the application submitted by the above firm for registration as a bulk manufacturer of the basic classes of controlled substances listed is granted.

Dated: July 22, 2003.

Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.

[FR Doc. 03-19814 Filed 8-4-03; 8:45 am]

BILLING CODE 4410-09-M

NOTICE: This is an unofficial version. An official version of this publication may be obtained directly from the Government Publishing Office (GPO).

Emergency Disaster Relief
National Prescription Drug Take Back Day. Turn in your unused or expired medication for safe disposal here.
RX Abuse Online

U.S. DEPARTMENT OF JUSTICE  •  DRUG ENFORCEMENT ADMINISTRATION
Diversion Control Division  •  8701 Morrissette Drive  •  Springfield, VA 22152  •  1-800-882-9539

DOJ Legal Policies and Disclaimers    |    DOJ Privacy Policy    |    FOIA    |    Section 508 Accessibility